Particle.news
Download on the App Store

Study Identifies tRNA‑Modifying Enzymes as Broad Coronavirus Antiviral Targets

Laboratory inhibition of stress‑activated tRNA modifiers reduced viral protein output, indicating a conserved coronavirus translation strategy.

Overview

  • Researchers at Pompeu Fabra University show that coronavirus infection triggers stress responses that chemically alter tRNAs, reprogramming host translation to favor viral protein synthesis.
  • The same host tRNA changes were detected in SARS‑CoV‑2 and in HCoV‑OC43, pointing to a mechanism likely shared across divergent coronaviruses.
  • Blocking the implicated tRNA‑modifying enzymes in cell models significantly decreased production of coronavirus proteins.
  • The peer‑reviewed study was published in Nature Communications and involved collaborators in Glasgow, Valencia, and Barcelona.
  • The authors highlight these enzymes as candidates for broad‑spectrum antivirals, noting the lack of such drugs and the early, preclinical stage of this research direction.